RES Group, Inc

Biotechnology ResearchMassachusetts, United States11-50 Employees

RES Group, Inc is a biotechnology research firm based in Needham Heights, Massachusetts, with a founding history linked to MIT and a focus on quantitative systems pharmacology modeling. Since 2001, the company has specialized in mechanistic modeling to support drug development, offering services such as first-in-human dose projections for IND applications and toxicity projections for regulatory submissions, along with early-stage development support. The organization positions itself as a partner for biotech and pharmaceutical companies seeking to de-risk and accelerate the development process through model-informed drug development approaches, contributing to over a hundred drug development efforts.

The client base comprises biotech and pharmaceutical companies that require precise dose forecasting and regulatory-oriented modeling to inform decision-making. RES Group operates within the biotechnology research sector, emphasizing quantitative modeling to address challenges in translating preclinical data to clinical outcomes. Notable recent examples involve FDA-acknowledged modeling work connected to submissions and regulatory decisions in complex therapeutic areas, reflecting the firm’s ongoing engagement with industry stakeholders seeking rigorous, evidence-based projections.

Sign up for free to view info

Email Format Employee directory